...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

ATTENTION MEMBERS: 

Tonight, we're giving our website a serious makeover.  

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.  

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache. 

See You On The Other Side!

Message: Re: EDITRe: i would love to hear,..
1
Dec 06, 2019 08:42AM
1
Dec 06, 2019 08:44AM
2
Dec 06, 2019 08:52AM
3
Dec 06, 2019 09:01AM

I understand.

But it does not necessarily follow that because the placebo (end of study) vs ABL (end of study) comparison was significant, so also was the ABL (end of study) vs ABL (baseline) comparison.

Share
New Message
Please login to post a reply